{
    "classes": [
        "SOFTNAME",
        "SOFTVERS",
        "STIME",
        "MOL",
        "FFM",
        "TEMP"
    ],
    "raw_text": "Rigorous Computational Study Reveals What Docking Overlooks: Double Trouble from Membrane Association in Protein Kinase C Modulators\nIncreasing protein kinase C (PKC) activity is of potential therapeutic value. Its activation involves an interaction between the C1 domain and diacylglycerol (DAG) at intracellular membrane surfaces; DAG mimetics hold promise as new drugs. We previously developed the isophthalate derivative HMI-1a3, an effective but highly lipophilic (clogP   6.46) DAG mimetic. Although a less lipophilic pyrimidine analog, PYR-1gP (clogP   3.30), gave positive results in computational docking, it unexpectedly presented greatly diminished binding to PKC in vitro. Through more rigorous computational molecular modeling, we reveal that, unlike HMI-1a3, PYR-1gP forms an intramolecular hydrogen bond, which both obstructs binding and reorients PYR-1gP in the membrane in a fashion that prevents it from correctly accessing the PKC C1 domain. Our results highlight the great value of molecular dynamics simulations as a key component for the drug design process of ligands targeting weakly membrane-associated proteins, where simulation in the relevant membrane environment is crucial for obtaining biologically applicable results.",
    "entities": [
        {
            "label": "MOL",
            "text": "Protein Kinase C",
            "start": 105,
            "end": 121
        },
        {
            "label": "MOL",
            "text": "protein kinase C",
            "start": 144,
            "end": 160
        },
        {
            "label": "MOL",
            "text": "PKC",
            "start": 162,
            "end": 165
        },
        {
            "label": "MOL",
            "text": "diacylglycerol",
            "start": 276,
            "end": 290
        },
        {
            "label": "MOL",
            "text": "DAG",
            "start": 292,
            "end": 295
        },
        {
            "label": "MOL",
            "text": "DAG",
            "start": 333,
            "end": 336
        },
        {
            "label": "MOL",
            "text": "isophthalate",
            "start": 401,
            "end": 413
        },
        {
            "label": "MOL",
            "text": "HMI-1a3",
            "start": 425,
            "end": 432
        },
        {
            "label": "MOL",
            "text": "DAG",
            "start": 484,
            "end": 487
        },
        {
            "label": "MOL",
            "text": "pyrimidine",
            "start": 524,
            "end": 534
        },
        {
            "label": "MOL",
            "text": "PYR-1gP",
            "start": 543,
            "end": 550
        },
        {
            "label": "MOL",
            "text": "PKC",
            "start": 671,
            "end": 674
        },
        {
            "label": "MOL",
            "text": "HMI-1a3",
            "start": 764,
            "end": 771
        },
        {
            "label": "MOL",
            "text": "PYR-1gP",
            "start": 773,
            "end": 780
        },
        {
            "label": "MOL",
            "text": "PYR-1gP",
            "start": 863,
            "end": 870
        },
        {
            "label": "MOL",
            "text": "PKC",
            "start": 946,
            "end": 949
        }
    ]
}